共 363 条
[1]
Gnjidic D(2012)Polypharmacy cutoff and outcomes: Five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes J Clin Epidemiol 65 989-995
[2]
Hilmer SN(2017)What is polypharmacy? A systematic review of definitions BMC Geriatr 17 230-65
[3]
Blyth FM(2014)Clinical Consequences of Polypharmacy in Elderly Expert Opin Drug Saf 13 57-225
[4]
Naganathan V(2015)The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995–2010 BMC Med 13 74-75
[5]
Waite L(2018)Medication usage change in older people (65+) in England over 20 years: Findings from CFAS I and CFAS II Age Ageing 47 220-85
[6]
Seibel MJ(2019)Polypharmacy among older Australians, 2006–2017: a population-based study Med J Aust 211 71-83
[7]
Masnoon N(2020)An overview of prevalence, determinants and health outcomes of polypharmacy Ther Adv Drug Saf 11 2042098620933741-603
[8]
Shakib S(2018)The deprescribing rainbow: a conceptual framework highlighting the importance of patient context when stopping medication in older people BMC Geriatr 18 295-90
[9]
Kalisch-Ellett L(2021)Prevalence and predictors of polypharmacy in Jordanian hospitalised patients: A cross-sectional Study Int J Clin Pract 75 e13742-69
[10]
Caughey GE(2019)Race/Ethnicity, Socioeconomic Status, and Polypharmacy among Older Americans Pharmacy 7 41-1237